Medical device for insertion into the human or animal body
A medical device according to the invention for insertion into a human and/or animal body comprises an elongated tubular lead probe including a proximal end portion and a distal end portion, an opening which opens into a lumen extending in the axial direction being formed on the proximal end of the lead probe, and the distal end of the lead probe being closed. The medical device further comprises an elongated core which is constructed in such a manner that it can be inserted into the lead probe and removed again via the lumen, and the core is made from non-metallic filaments and a matrix material.
1. A medical device for insertion into a human or animal body, comprising
an elongated, tubular lead probe including a proximal end portion and a distal end portion, the proximal end of the lead probe being provided with an opening which opens into a lumen extending in the axial direction, and the distal end of the lead probe being closed,
an elongated core,
the core being designed in such a manner that it can be inserted into the lead probe via the opening into the lumen, characterized in that
the core is made from non-metallic filaments which are embedded in a matrix material.
2. The medical device according to claim 1 ,
characterized in that
the diameter of the core amounts to approximately 60% to 98% of the diameter of the lumen of the lead probe.
3. The medical device according to claim 1 ,
characterized in that
the core has a higher flexural rigidity than the lead probe.
4. The medical device according to claim 1 , characterized in that
the core comprises a magnetic resonance tomography (“MRT”) marker which extends over a major part of the length of the core.
5. The medical device according to claim 4 ,
characterized in that
the core has its distal end portion provided with an MRT marker.
6. The medical device according to claim 4 ,
characterized in that
the MRT marker is formed from microparticles or nanoparticles made of one of the following metals or metallic compounds: cobalt (Co), nickel (Ni), molybdenum (Mo), zirconium (Zr), titanium (Ti), manganese (Mn), rubidium (Rb), aluminum (Al), palladium (Pd), platinum (Pt), chromium (Cr) or chromium dioxide (CrO2), iron (Fe), iron oxide (FeO, Fe2O3, Fe3O4), and FePt.
7. The medical device according to claim 4 , characterized in that
the MRT markers are concentrated along the centric longitudinal axis of the core.
8. The medical device according to claim 1 , characterized in that
the core comprises X-ray markers.
9. The medical device according to claim 1 , characterized in that
the non-metallic filaments are formed from glass fibers, ceramic fibers, Dacron®, aramide, polyaramide, Kevlar®, Dyneema® and/or vegetable fibers.
10. The medical device according to claim 1 , characterized in that
the core comprises aramide fibers and glass fibers.
11. The medical device according to claim 1 , characterized in that
the core is formed from one or more elongated compound elements which are each formed from the non-metallic filaments embedded in the matrix material, and the compound element(s) being embedded in a cladding matrix.
12. The medical device according to claim 1 , characterized in that
an electrode is arranged in the proximal end portion of the lead probe, so that the medical device constitutes a cardiac pacemaker probe.
13. The medical device according to claim 1 , characterized in that
the medical device comprises a rod-shaped body which can be inserted into the lead probe instead of the core, the rod-shaped body comprising a radiation source.
14. The medical device according to claim 13 ,
characterized in that
the lead probe is made from a rigid material.
15. The medical device according to claim 13 ,
characterized in that
the lead probe is made from a flexible material.
16. A method of positioning a medical device in a human or animal body, wherein a medical device according to claim 1 is inserted into the human or animal body.
17. The method according to claim 16 ,
characterized in that
the flexural rigidity of the medical device is altered at least in the distal end portion by shifting the core in the lead probe.
18. The method according to claim 16 ,
characterized in that
the core comprises MRT markers and/or X-ray markers, whereby the position of the medical device in the human or animal body is detected by an MRT or X-ray examination during insertion of the medical device.
19. The method according to claim 16 , characterized in that
the medical device is used as a pacemaker probe.
20. The method according to claim 16 , characterized in that
the medical device is used for brachytherapy.